Clovis Oncology Inc (NASDAQ:CLVS)

5.71
Delayed Data
As of May 12
 +0.10 / +1.78%
Today’s Change
4.08
Today|||52-Week Range
11.10
+18.96%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 5.88, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +2.89% increase from the last price of 5.71.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.56
Sales
$41.1M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.98%
 
 
 
 
 
 
Growthannually 48.21%
 
 
 
 
 
 

Sales

Growthquarterly 8.08%
 
 
 
 
 
 
Growthannually 5.93%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.